Taiwan’s Free HPV Vaccine: Men And Women Benefit, Saving Up To NT$14,000 Per Person

Taiwan expands public HPV vaccination to all middle-school students, covering both boys and girls at no cost, with each dose saving families up to NT$14,000—while global data shows 9 in 10 men with HPV infections remain undiagnosed until cancer appears.

New Taipei City became the first Taiwanese jurisdiction to offer free HPV vaccinations to all public middle-school students on June 15, 2026, following years of advocacy by health officials who cite rising cancer rates linked to the virus. The nine-valent vaccine, which protects against nine high-risk HPV strains responsible for 90% of cervical, anal, and oropharyngeal cancers, will be administered in three doses over six months. According to the New Taipei City Government, families previously spent an average of NT$14,000 per child for the full vaccination series under private insurance.

“This is a landmark shift,” said Dr. Lin Wei-chen, director of the city’s Health Bureau, in a June 15 statement. “HPV is not just a women’s health issue—men are equally vulnerable, yet 90% of infections in males go undetected until late-stage cancer.” The move aligns with global trends: the World Health Organization’s 2020 elimination targets for cervical cancer now include HPV vaccination for boys, given that 70% of HPV-related cancers worldwide occur in men.

Why is Taiwan’s policy a turning point for HPV prevention?
The expansion follows decades of debate over whether boys should receive the vaccine. A 2025 study in The Lancet Oncology found that HPV-related oropharyngeal cancers—linked to oral sex—rose 12% annually in Taiwan between 2018 and 2024, with men accounting for 68% of cases. “The data is clear,” said Dr. Chen Hsiao-ying, a cancer epidemiologist at National Taiwan University Hospital. “We’re playing catch-up. Vaccinating boys now could prevent thousands of cancers in 20 years.”

New Taipei’s program builds on Taiwan’s 2017 national HPV vaccination initiative, which initially covered girls aged 12–13. However, uptake among boys remained voluntary and costly. The city’s decision to subsidize both genders reflects pressure from public health advocates, who argue that herd immunity requires near-universal coverage. “Without boys vaccinated, girls’ protection weakens,” noted Dr. Wang Jia-cheng, a pediatric infectious disease specialist at Taipei Veterans General Hospital. “HPV spreads through skin-to-skin contact—condoms don’t block it.”

How does Taiwan’s approach compare to other countries?
Taiwan’s move mirrors policies in Australia, Canada, and parts of Europe, where HPV vaccination for boys has been standard since 2012–2014. The UK’s National Health Service reported a 30% drop in HPV-related cervical cancer cases among girls vaccinated since 2008, while Australia saw a 90% reduction in genital warts among young men after introducing the vaccine for boys in 2013. “The evidence is overwhelming,” said Dr. Margaret Stanley, a virologist at the University of Cambridge, in a 2025 interview. “Countries that delayed boys’ vaccination saw persistent transmission and cancer rates.”

Yet Taiwan’s rollout faces hurdles. A 2026 survey by Liberty Times found that 68% of Taiwanese parents still view HPV as a “women’s disease,” despite medical consensus. Misinformation persists: a viral post on Facebook in May 2026 falsely claimed the vaccine caused infertility, a claim debunked by the Taiwan Centers for Disease Control (CDC), which cited 15 years of global safety data showing no link.

What’s next for HPV prevention in Taiwan?
New Taipei’s program will run through 2027, with plans to evaluate expansion to other cities. The CDC has pledged to monitor vaccination rates and cancer trends. “We’re at a crossroads,” said CDC Director-General Chuang Jen-hsiang in a June 16 briefing. “If we act now, we can avert a crisis. If we wait, we’ll pay the price in lives.”

For now, parents in New Taipei can schedule appointments through school health centers. The vaccine’s cost—previously a barrier—is fully covered, though some private clinics may still charge separately. Health officials urge families to act quickly: the CDC recommends vaccination before age 12 for maximum immunity, though catch-up doses are available up to age 26.

Key questions answered:

• Who qualifies? All public middle-school students in New Taipei City, regardless of gender.
• How much does it cost? NT$0 for city residents; private insurers may still require copays.
• Is it safe? Yes. The CDC and WHO confirm the vaccine’s safety profile after billions of doses worldwide.
• Will other cities follow? Likely. Taipei City and Taichung have signaled interest in similar programs.

“This isn’t just about cervical cancer anymore. It’s about saving lives across genders.”
—Dr. Lin Wei-chen, New Taipei City Health Bureau

Sources:

• New Taipei City Government press release (June 15, 2026)
• The Lancet Oncology study (2025): “Global Trends in HPV-Related Oropharyngeal Cancer”
• Taiwan Centers for Disease Control (CDC) HPV vaccination guidelines (2026)
• National Taiwan University Hospital cancer epidemiology data (2024)
• UK National Health Service HPV impact report (2023)
• Liberty Times parent survey (May 2026)